Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes

Experimental Hematology

Volumn 29, Issue 12, 2001, Pages 1403-1409

  Ware, Russell E ^a   Pickens, Chrisley V ^a   DeCastro, Carlos M ^b   Howard, Thad A ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROLYSIN;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CELL CLONING; CELL ISOLATION; CONTROLLED STUDY; FANCONI ANEMIA; FEMALE; HUMAN; HUMAN CELL; MALE; MUTANT; MUTATION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; T LYMPHOCYTE; TECHNIQUE;

ADULT; ANEMIA, APLASTIC; ANTIGENS, CD; BACTERIAL TOXINS; BONE MARROW DISEASES; CELL SEPARATION; CLONE CELLS; DNA, COMPLEMENTARY; GENETIC COMPLEMENTATION TEST; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MEMBRANE PROTEINS; MUTATION; MYELODYSPLASTIC SYNDROMES; PORE FORMING CYTOTOXIC PROTEINS; REFERENCE VALUES; T-LYMPHOCYTES;

AEROMONAS;

EID: 0035655579     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00746-9     Document Type: Article

References (51)

1. Paroxysmal nocturnal hemoglobinuria
2. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence
3. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin
4. Late clonal complications in severe aplastic anemia
5. The aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome
6. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria
7. Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor
8. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria
9. Deficient biosynthesis of N-Acetylglucosaminyl-phosphatidyl-inositol, the first intermediate of glycosyl phosphatidyl-inositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria
10. Defective glycosylphosphatidyl-inositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes
11. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria
12. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis
13. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria
14. Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria
15. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene
16. Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria
17. Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria
18. Somatic mutations of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria
19. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type
20. The molecular basis of paroxysmal nocturnal hemoglobinuria
21. Development of the glycosylphosphatidylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia
22. Aplastic anemia and paroxysmal nocturnal hemoglobinuria; Search for a pathogenetic link
23. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia
24. Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma
25. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment
26. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals
27. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria
28. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood
29. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans
30. Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states
31. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin
32. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin
33. Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria; Partial or complete defect in an early step
34. Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria
35. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria
36. A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones
37. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro
38. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes
39. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone
40. Glycosylphosphatidylinositol-anchor-deficient mice; Implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria
41. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion
42. Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene
43. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria
44. The problem of clonality in aplastic anemia; Dr. Dameshek's riddle, restated
45. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria
46. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome
47. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria
48. Genetic instability and the etiology of somatic PIG-A mutations in paroxysmal nocturnal hemoglobinuria
49. Identification and characterization of an inherited mutation of PIG-A in a patient with paroxysmal nocturnal haemoglobinuria
50. The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications
51. Acquired DNA mutations associated with in vivo hydroxy-urea exposure